Comparison

Lenalidomide European Partner

Manufacturer Abbexa
Category
Type Small Molecules
Specific against other
Amount 10 mg
Item no. abx076543-10
eClass 6.1 32160401
eClass 9.0 32160401
Available
Antigen
Lenalidomide
Description
Lenalidomide is a small molecule. Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquitin ligase. This ultimately leads to the degradation of IKZF1 and IKZF2, which are both essential in myeloma cell survival.
Origin
Synthetic
Purity
>98% (TLC); NMR (Conforms)
Storage
Store at -20 C.
Molecular Weight
259.26 g/mol
Dry Ice
No
Note
This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close